C22orf15
gene geneOn this page
Also known as FLJ36561N27C7-3
Summary
C22orf15 (chromosome 22 open reading frame 15, HGNC:15558) is a protein-coding gene on chromosome 22q11.23, encoding Uncharacterized protein C22orf15 (Q8WYQ4).
At a glance
- Clinical variants (ClinVar): 15 total — 1 pathogenic
- MANE Select transcript:
NM_182520
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15558 |
| Approved symbol | C22orf15 |
| Name | chromosome 22 open reading frame 15 |
| Location | 22q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ36561, N27C7-3 |
| Ensembl gene | ENSG00000169314 |
| Ensembl biotype | protein_coding |
| Entrez | 150248 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 2 retained_intron
ENST00000305199, ENST00000382821, ENST00000402217, ENST00000477921, ENST00000498542, ENST00000877953, ENST00000877954, ENST00000933350, ENST00000933351, ENST00000933352, ENST00000933353, ENST00000933354, ENST00000956167
RefSeq mRNA: 5 — MANE Select: NM_182520
NM_001331041, NM_001376903, NM_001376904, NM_001376905, NM_182520
CCDS: CCDS13814, CCDS82698, CCDS93130
Canonical transcript exons
ENST00000402217 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001153579 | 23764260 | 23764397 |
| ENSE00001843329 | 23762990 | 23763331 |
| ENSE00003498479 | 23765721 | 23765863 |
| ENSE00003517106 | 23764639 | 23764713 |
| ENSE00003606373 | 23764793 | 23764902 |
| ENSE00003670968 | 23764087 | 23764173 |
Expression profiles
Bgee: expression breadth ubiquitous, 123 present calls, max score 93.44.
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 93.44 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.63 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.67 | gold quality |
| fallopian tube | UBERON:0003889 | 77.60 | gold quality |
| right testis | UBERON:0004534 | 68.80 | gold quality |
| right lung | UBERON:0002167 | 68.35 | gold quality |
| ventricular zone | UBERON:0003053 | 67.73 | gold quality |
| left testis | UBERON:0004533 | 67.67 | gold quality |
| testis | UBERON:0000473 | 67.63 | gold quality |
| pituitary gland | UBERON:0000007 | 66.06 | gold quality |
| adenohypophysis | UBERON:0002196 | 63.07 | gold quality |
| left uterine tube | UBERON:0001303 | 62.54 | gold quality |
| granulocyte | CL:0000094 | 60.59 | gold quality |
| lung | UBERON:0002048 | 59.73 | gold quality |
| vermiform appendix | UBERON:0001154 | 58.32 | gold quality |
| lymph node | UBERON:0000029 | 58.31 | gold quality |
| left ovary | UBERON:0002119 | 57.71 | gold quality |
| ovary | UBERON:0000992 | 57.29 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 56.82 | gold quality |
| bone marrow | UBERON:0002371 | 56.12 | gold quality |
| endocervix | UBERON:0000458 | 55.97 | gold quality |
| myometrium | UBERON:0001296 | 55.95 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 55.26 | silver quality |
| placenta | UBERON:0001987 | 55.22 | gold quality |
| muscle tissue | UBERON:0002385 | 55.15 | gold quality |
| gall bladder | UBERON:0002110 | 54.95 | gold quality |
| gastrocnemius | UBERON:0001388 | 54.85 | gold quality |
| liver | UBERON:0002107 | 54.84 | gold quality |
| hypothalamus | UBERON:0001898 | 54.62 | gold quality |
| blood | UBERON:0000178 | 54.45 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.54 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting C22orf15, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-6134 | 99.63 | 65.68 | 1537 |
| HSA-MIR-6742-5P | 96.32 | 64.01 | 869 |
| HSA-MIR-6735-3P | 96.10 | 63.81 | 600 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm867 | ENSMUSG00000050157 |
| rattus_norvegicus | C20h22orf15 | ENSRNOG00000028386 |
Protein
Protein identifiers
Uncharacterized protein C22orf15 — Q8WYQ4 (reviewed: Q8WYQ4)
Alternative names: Protein N27C7-3
All UniProt accessions (2): Q8WYQ4, F8W7S3
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WYQ4-1 | 1 | yes |
| Q8WYQ4-2 | 2 |
RefSeq proteins (5): NP_001317970, NP_001363832, NP_001363833, NP_001363834, NP_872326* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039471 | CXorf65-like | Family |
Pfam: PF15874
UniProt features (5 total): splice variant 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WYQ4-F1 | 76.10 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 29 (showing top):
RYTTCCTG_ETS2_B, ETS_Q4, ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP, DODD_NASOPHARYNGEAL_CARCINOMA_DN, DELACROIX_RAR_BOUND_ES, DACH1_TARGET_GENES, ZNF513_TARGET_GENES, ZNF528_TARGET_GENES, GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN, RTAAACA_FREAC2_01, MANNO_MIDBRAIN_NEUROTYPES_HRGL2C, MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL, MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM, ETS2_B, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
128 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C22orf15 | LRRC75B | Q2VPJ9 | 718 |
| C22orf15 | DRICH1 | Q6PGQ1 | 602 |
| C22orf15 | GUCD1 | Q96NT3 | 577 |
| C22orf15 | ZNF70 | Q9UC06 | 527 |
| C22orf15 | GSTT4 | A0A1W2PR19 | 512 |
| C22orf15 | DDTL | A6NHG4 | 507 |
| C22orf15 | RGL4 | Q8IZJ4 | 479 |
| C22orf15 | ZNF74 | Q16587 | 445 |
| C22orf15 | SGSM1 | Q2NKQ1 | 434 |
| C22orf15 | SPECC1L | Q69YQ0 | 403 |
| C22orf15 | DGCR2 | P98153 | 401 |
| C22orf15 | UPB1 | Q9UBR1 | 395 |
| C22orf15 | H7C1H1 | H7C1H1 | 393 |
| C22orf15 | SLC2A11 | Q9BYW1 | 392 |
| C22orf15 | VPREB3 | Q9UKI3 | 370 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C22orf15 | GATB | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (22): C22orf15 (Two-hybrid), C22orf15 (Two-hybrid), C22orf15 (Two-hybrid), C22orf15 (Two-hybrid), C22orf15 (Two-hybrid), C22orf15 (Two-hybrid), BANP (Two-hybrid), HSPA6 (Two-hybrid), HSPB7 (Two-hybrid), CCDC125 (Two-hybrid), KCTD21 (Two-hybrid), GOLGA6L9 (Two-hybrid), NPAT (Affinity Capture-MS), MTIF2 (Affinity Capture-MS), LIMK1 (Affinity Capture-MS)
ESM2 similar proteins: A5A6J5, A6QLZ5, O08838, O75618, O77768, O95684, O95983, P07910, P49418, P63042, P63043, Q08DJ0, Q15014, Q2YDD1, Q32KN2, Q32PC9, Q4R578, Q4R7V3, Q4R930, Q4V7C1, Q4V8C5, Q5E948, Q5R467, Q5R724, Q5R905, Q5R9K8, Q5RA82, Q5RD48, Q5REE1, Q5RJZ6, Q5UAK0, Q66HC7, Q66JX5, Q6QI89, Q7TT00, Q86SE5, Q8BR63, Q8BTF8, Q8N108, Q8N128
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
15 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 442258 | GRCh37/hg19 22q11.23(chr22:23690387-24666092)x1 | Pathogenic |
SpliceAI
1122 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:23764170:GATG:G | donor_gain | 1.0000 |
| 22:23764254:TCCCA:T | acceptor_loss | 1.0000 |
| 22:23764256:CCA:C | acceptor_loss | 1.0000 |
| 22:23764257:CAG:C | acceptor_loss | 1.0000 |
| 22:23764258:A:AG | acceptor_gain | 1.0000 |
| 22:23764258:A:C | acceptor_loss | 1.0000 |
| 22:23764258:AGC:A | acceptor_gain | 1.0000 |
| 22:23764259:G:GA | acceptor_gain | 1.0000 |
| 22:23764259:GCG:G | acceptor_gain | 1.0000 |
| 22:23764259:GCGA:G | acceptor_gain | 1.0000 |
| 22:23764398:G:GG | donor_gain | 1.0000 |
| 22:23764630:A:AG | acceptor_gain | 1.0000 |
| 22:23764630:AT:A | acceptor_gain | 1.0000 |
| 22:23764631:T:G | acceptor_gain | 1.0000 |
| 22:23763305:C:G | donor_gain | 0.9900 |
| 22:23763328:GGGG:G | donor_gain | 0.9900 |
| 22:23763329:GGGG:G | donor_gain | 0.9900 |
| 22:23764085:A:AG | acceptor_gain | 0.9900 |
| 22:23764086:G:GG | acceptor_gain | 0.9900 |
| 22:23764086:GCT:G | acceptor_gain | 0.9900 |
| 22:23764173:GGTGA:G | donor_loss | 0.9900 |
| 22:23764174:G:C | donor_loss | 0.9900 |
| 22:23764175:T:A | donor_loss | 0.9900 |
| 22:23764186:G:GT | donor_gain | 0.9900 |
| 22:23764259:GC:G | acceptor_gain | 0.9900 |
| 22:23764259:GCGAC:G | acceptor_gain | 0.9900 |
| 22:23764260:C:CA | acceptor_gain | 0.9900 |
| 22:23764275:T:TA | acceptor_gain | 0.9900 |
| 22:23764319:G:GT | donor_gain | 0.9900 |
| 22:23764364:G:GT | donor_gain | 0.9900 |
AlphaMissense
944 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:23763310:T:C | F2L | 0.989 |
| 22:23763312:T:A | F2L | 0.989 |
| 22:23763312:T:G | F2L | 0.989 |
| 22:23764272:T:A | L42H | 0.985 |
| 22:23764380:T:A | V78D | 0.981 |
| 22:23764144:T:C | L28P | 0.977 |
| 22:23764287:G:T | G47V | 0.971 |
| 22:23764386:T:A | V80D | 0.971 |
| 22:23764132:T:C | L24P | 0.969 |
| 22:23763325:T:C | F7L | 0.968 |
| 22:23763327:T:A | F7L | 0.968 |
| 22:23763327:T:G | F7L | 0.968 |
| 22:23764272:T:C | L42P | 0.968 |
| 22:23764383:T:A | L79H | 0.968 |
| 22:23763311:T:C | F2S | 0.961 |
| 22:23764272:T:G | L42R | 0.959 |
| 22:23763311:T:G | F2C | 0.956 |
| 22:23764109:C:A | N16K | 0.954 |
| 22:23764109:C:G | N16K | 0.954 |
| 22:23764144:T:A | L28Q | 0.954 |
| 22:23764799:T:C | L111P | 0.953 |
| 22:23764116:T:C | C19R | 0.949 |
| 22:23764376:T:G | Y77D | 0.949 |
| 22:23764268:G:C | A41P | 0.947 |
| 22:23764144:T:G | L28R | 0.943 |
| 22:23764108:A:T | N16I | 0.941 |
| 22:23764275:T:C | L43P | 0.941 |
| 22:23763314:T:A | I3N | 0.933 |
| 22:23764665:T:G | Y93D | 0.930 |
| 22:23763328:G:T | G8W | 0.929 |
dbSNP variants (sampled 300 via entrez): RS1000149115 (22:23762123 C>A), RS1000462749 (22:23765941 T>C), RS1000576672 (22:23766146 GC>G), RS1001152107 (22:23761071 G>A), RS1001735342 (22:23762969 G>A), RS1002030198 (22:23765436 T>C,G), RS1002993710 (22:23763547 C>T), RS1003024804 (22:23763760 G>A,T), RS1003808195 (22:23764204 G>A), RS1003997041 (22:23765649 T>C), RS1004130938 (22:23761428 G>A,T), RS1005004159 (22:23764217 C>T), RS1005027610 (22:23765208 G>T), RS1005809221 (22:23762300 A>C,T), RS1006212087 (22:23762487 T>A)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:613500, MIM:615048, MIM:615911, MIM:616209
GenCC curated gene-disease
Mondo (4): agammaglobulinemia 2, autosomal recessive (MONDO:0013287), lower motor neuron syndrome with late-adult onset (MONDO:0014025), frontotemporal dementia and/or amyotrophic lateral sclerosis 2 (MONDO:0014395), autosomal dominant mitochondrial myopathy with exercise intolerance (MONDO:0014532)
Orphanet (3): Frontotemporal dementia with motor neuron disease (Orphanet:275872), Lower motor neuron syndrome with late-adult onset (Orphanet:276435), Autosomal dominant mitochondrial myopathy with exercise intolerance (Orphanet:457050)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Estradiol | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Triclosan | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): agammaglobulinemia 2, autosomal recessive, autosomal dominant mitochondrial myopathy with exercise intolerance, frontotemporal dementia and/or amyotrophic lateral sclerosis 2, lower motor neuron syndrome with late-adult onset